Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1966297rdf:typepubmed:Citationlld:pubmed
pubmed-article:1966297lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:1966297lifeskim:mentionsumls-concept:C0023660lld:lifeskim
pubmed-article:1966297lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:1966297lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:1966297lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:1966297lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:1966297lifeskim:mentionsumls-concept:C1150572lld:lifeskim
pubmed-article:1966297pubmed:issue4lld:pubmed
pubmed-article:1966297pubmed:dateCreated1991-9-13lld:pubmed
pubmed-article:1966297pubmed:abstractTextThe effects of lidocaine, a local anesthetic, on various stimulation-coupled responses of neutrophils were studied. Superoxide generation, generation of chemiluminescence, depolarization of membrane potential and transitional increase in intracellular Ca2+ were inhibited by lidocaine in a concentration dependent manner. Lidocaine also inhibited Ca(2+)-activated phospholipid-dependent protein kinase (PKC) in the presence of various concentrations of Ca2+, phosphatidylserine and dioleoylglycerol. For the inhibition of all these stimulation-coupled responses, a similar order of the lidocaine concentration was needed. As in the case of dibucaine (Mori, T., Takai, Y., Minakuchi, R., Yu, B. and Nishizuka, Y., J. Biol. Chem. 255:8378-8380, 1980), lidocaine inhibited PKC activity in a manner competitive with phosphatidylserine. Lidocaine also inhibited the phosphorylation of 47 kDa neutrophil cytosplasmic protein, a phosphorylated protein required for NADPH oxidase activation. Thus, the cellular membrane phospholipid may be one of the target sites of lidocaine for the inhibitory action on the various stimulation-coupled responses of neutrophils, and these effects of lidocaine may correlate with its inhibitory action on PKC activity.lld:pubmed
pubmed-article:1966297pubmed:languageenglld:pubmed
pubmed-article:1966297pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1966297pubmed:citationSubsetIMlld:pubmed
pubmed-article:1966297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1966297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1966297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1966297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1966297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1966297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1966297pubmed:statusMEDLINElld:pubmed
pubmed-article:1966297pubmed:issn0748-6642lld:pubmed
pubmed-article:1966297pubmed:authorpubmed-author:UtsumiKKlld:pubmed
pubmed-article:1966297pubmed:authorpubmed-author:TsuchiyaMMlld:pubmed
pubmed-article:1966297pubmed:authorpubmed-author:HirakawaMMlld:pubmed
pubmed-article:1966297pubmed:authorpubmed-author:UedaWWlld:pubmed
pubmed-article:1966297pubmed:authorpubmed-author:TomodaM KMKlld:pubmed
pubmed-article:1966297pubmed:issnTypePrintlld:pubmed
pubmed-article:1966297pubmed:volume22lld:pubmed
pubmed-article:1966297pubmed:ownerNLMlld:pubmed
pubmed-article:1966297pubmed:authorsCompleteYlld:pubmed
pubmed-article:1966297pubmed:pagination199-210lld:pubmed
pubmed-article:1966297pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:meshHeadingpubmed-meshheading:1966297-...lld:pubmed
pubmed-article:1966297pubmed:year1990lld:pubmed
pubmed-article:1966297pubmed:articleTitleLidocaine inhibits stimulation-coupled responses of neutrophils and protein kinase C activity.lld:pubmed
pubmed-article:1966297pubmed:affiliationDepartment of Anesthesiology, Kochi Medical School, Japan.lld:pubmed
pubmed-article:1966297pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1966297pubmed:publicationTypeIn Vitrolld:pubmed